1onf: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1onf.png|left|200px]] | [[Image:1onf.png|left|200px]] | ||
{{STRUCTURE_1onf| PDB=1onf | SCENE= }} | {{STRUCTURE_1onf| PDB=1onf | SCENE= }} | ||
===Crystal structure of Plasmodium falciparum Glutathione reductase=== | ===Crystal structure of Plasmodium falciparum Glutathione reductase=== | ||
{{ABSTRACT_PUBMED_12729762}} | {{ABSTRACT_PUBMED_12729762}} | ||
==About this Structure== | ==About this Structure== | ||
[[1onf]] is a 1 chain structure of [[Glutathione Reductase]] with sequence from [http://en.wikipedia.org/wiki/Plasmodium_falciparum Plasmodium falciparum]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1ONF OCA]. | |||
==See Also== | |||
*[[Glutathione Reductase|Glutathione Reductase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:012729762</ref><ref group="xtra">PMID:016516468</ref><references group="xtra"/> | ||
[[Category: Glutathione-disulfide reductase]] | [[Category: Glutathione-disulfide reductase]] | ||
[[Category: Plasmodium falciparum]] | [[Category: Plasmodium falciparum]] | ||
| Line 33: | Line 24: | ||
[[Category: Schirmer, R H.]] | [[Category: Schirmer, R H.]] | ||
[[Category: Oxidoreductase]] | [[Category: Oxidoreductase]] | ||
Revision as of 16:20, 26 July 2012
Crystal structure of Plasmodium falciparum Glutathione reductaseCrystal structure of Plasmodium falciparum Glutathione reductase
Template:ABSTRACT PUBMED 12729762
About this StructureAbout this Structure
1onf is a 1 chain structure of Glutathione Reductase with sequence from Plasmodium falciparum. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Sarma GN, Savvides SN, Becker K, Schirmer M, Schirmer RH, Karplus PA. Glutathione reductase of the malarial parasite Plasmodium falciparum: crystal structure and inhibitor development. J Mol Biol. 2003 May 9;328(4):893-907. PMID:12729762
- ↑ Joshi AA, Viswanathan CL. Docking studies and development of novel 5-heteroarylamino-2,4-diamino-8-chloropyrimido-[4,5-b]quinolines as potential antimalarials. Bioorg Med Chem Lett. 2006 May 15;16(10):2613-7. Epub 2006 Mar 3. PMID:16516468 doi:10.1016/j.bmcl.2006.02.038